Five years of JCOM ― inclusive, comprehensive or could we do better?
نویسندگان
چکیده
منابع مشابه
Preventing invasive candida infections. Where could we do better?
Invasive candidiasis is associated with high mortality rates, ranging from 35% to 60%, in the range reported for septic shock. The epidemiology and pathogenesis of invasive candidiasis differ according to the patient's immune status; the majority of cases in immunocompromised hosts are candidaemia, whereas non-candidaemic systemic candidiasis accounts for the majority of cases in critically ill...
متن کاملReturns on IT Investment: Could We Do Better?
Spending on IT continues to show long-term growth throughout the economy, apparently reflecting a belief in the economic benefits of IT. However, we also see organizations struggle in practice to demonstrate such benefits. Conventional thinking suggests that individual organizations can improve their performance in this area through better financial analysis of opportunities. But does this char...
متن کاملInfection Prophylaxis for Breast Implant Surgery: Could We Do Better?
Objective: Infective complications following breast implant surgery may result in implant removal. This causes patient distress and is costly to treat. A range of precautions is undertaken at the time of surgery to reduce infection, with varying levels of supporting evidence. This study aimed to determine how frequently and consistently infection prevention precautions are used during breast im...
متن کامل“Evidence-Based Dentistry in Oral Surgery: Could We Do Better?”
Evidence-based Dentistry (EBD), like Evidence-based Medicine (EBM), was born in order to seek the "best available research evidence" in the field of dentistry both in research and clinical routine.BUT EVIDENCE IS NOT CLEARLY MEASURABLE IN ALL FIELDS OF HEALTHCARE: in particular, while drug effect is rather independent from clinician's characteristics, the effectiveness of surgical procedures is...
متن کاملPrevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?
The prevalence of chronic renal diseases is increasing worldwide. There is a great need to identify therapies that arrest disease progression to end-stage renal failure. Inhibition of renin-angiotensin system both by ACE inhibitors and angiotensin II receptor antagonists is probably the best therapeutic option available. Several large, multicenter studies have indeed shown a significant reducti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Science Communication
سال: 2016
ISSN: 1824-2049
DOI: 10.22323/2.15040501